Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 11;35(1):e100751.
doi: 10.1136/gpsych-2022-100751. eCollection 2022.

The China Alzheimer Report 2022

Rujing Ren #  1 , Jinlei Qi #  2 , Shaohui Lin #  3 , Xinya Liu #  4   5 , Peng Yin  2 , Zhihui Wang  2 , Ran Tang  1 , Jintao Wang  1 , Qiang Huang  1 , Jianping Li  1 , Xinyi Xie  1 , Yongbo Hu  1 , Shishuang Cui  1 , Yuan Zhu  1 , Xiaoping Yu  1 , Pengfei Wang  4   5 , Yikang Zhu  3 , Yiran Wang  3 , Yanyan Huang  6 , Yisong Hu  7 , Ying Wang  4   5 , Chunbo Li  3 , Maigeng Zhou  2 , Gang Wang  1
Affiliations
Review

The China Alzheimer Report 2022

Rujing Ren et al. Gen Psychiatr. .

Abstract

China's population has rapidly aged over the recent decades of social and economic development as neurodegenerative disorders have proliferated, especially Alzheimer's disease (AD) and related dementias (ADRD). AD's incidence rate, morbidity, and mortality have steadily increased to make it presently the fifth leading cause of death among urban and rural residents in China and magnify the resulting financial burdens on individuals, families and society. The 'Healthy China Action' plan of 2019-2030 promotes the transition from disease treatment to health maintenance for this expanding population with ADRD. This report describes related epidemiological trends, evaluates the economic burden of the disease, outlines current clinical diagnosis and treatment status and delineates existing available public health resources. More specifically, it examines the public health impact of ADRD, including prevalence, mortality, costs, usage of care, and the overall effect on caregivers and society. In addition, this special report presents technical guidance and supports for the prevention and treatment of AD, provides expertise to guide relevant governmental healthcare policy development and suggests an information platform for international exchange and cooperation.

Keywords: cognition disorders; economics, behavioral; public health administration.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Change in the ranking of Alzheimer’s disease and related dementias deaths in China from 1990 to 2019. COPD, chronic obstructive pulmonary disease.
Figure 2
Figure 2
Change in the DALY ranking of Alzheimer’s disease and related dementias in China from 1990 to 2019. COPD, chronic obstructive pulmonary disease; DALY, disability-adjusted life year.
Figure 3
Figure 3
Distinguishing normal controls (NC) from mild cognitive impairment (MCI) and Alzheimer’s disease (AD) using a self-developed software programme for speech analysis.
Figure 4
Figure 4
Alzheimer’s disease therapy trials registered on ClinicalTrials.gov.
Figure 5
Figure 5
Alzheimer’s disease therapy trials registered on chictr.org.cn.
See this image and copyright information in PMC

References

    1. National Bureau of Statistics . The seventh national census of China. Available: http://www.stats.gov.cn/tjsj/zxfb/202105/t20210510_1817181.html [Accessed 10 Dec 2021].
    1. National Bureau of Statistics . The sixth national census of China. Available: http://www.stats.gov.cn/tjsj/tjgb/rkpcgb/qgrkpcgb/201104/t20110428_30327... [Accessed 10 Dec 2021].
    1. Zhou M, Wang H, Zeng X, et al. . Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet 2019;394:1145–58. 10.1016/S0140-6736(19)30427-1 - DOI - PMC - PubMed
    1. Zhang Y-Q, Wang C-F, Xu G, et al. . Mortality of Alzheimer's disease patients: a 10-year follow-up pilot study in Shanghai. Can J Neurol Sci 2020;47:226–30. 10.1017/cjn.2019.333 - DOI - PubMed
    1. Jia L, Du Y, Chu L, et al. . Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health 2020;5:e661–71. 10.1016/S2468-2667(20)30185-7 - DOI - PubMed

LinkOut - more resources